Kexing Biopharm Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	5,983	4,323	4,034	4,260	5,617	8,115
Market Cap Growth	76.92%	7.17%	-5.31%	-24.16%	-30.78%	-
Enterprise Value	6,770	5,012	4,566	4,432	5,203	8,278
Last Close Price	30.20	21.83	20.22	21.41	28.13	40.55
PE Ratio	48.73	137.32	-	-	58.23	58.32
PS Ratio	3.95	3.07	3.20	3.24	4.37	6.65
PB Ratio	3.49	2.64	2.47	2.36	2.94	4.43
P/TBV Ratio	4.05	3.07	2.75	2.59	2.98	4.53
P/FCF Ratio	-	340.98	-	-	-	-
P/OCF Ratio	129.66	40.53	-	-	59.75	76.61
EV/Sales Ratio	4.46	3.56	3.63	3.37	4.05	6.78
EV/EBITDA Ratio	33.08	27.15	-	-	67.21	39.86
EV/EBIT Ratio	70.62	50.87	-	-	123.25	46.36
EV/FCF Ratio	-216.69	395.29	-	-	-	-
Debt / Equity Ratio	0.82	0.75	0.68	0.57	0.32	0.17
Debt / EBITDA Ratio	6.83	6.18	-	-	6.53	1.52
Debt / FCF Ratio	-	96.29	-	-	-	-
Net Debt / Equity Ratio	0.46	0.41	0.34	0.14	-0.14	-0.43
Net Debt / EBITDA Ratio	4.10	3.61	-3.26	-3.60	-3.57	-3.79
Net Debt / FCF Ratio	-25.13	52.55	-1.97	-0.52	0.99	9.48
Asset Turnover	0.47	0.45	0.41	0.44	0.50	0.69
Inventory Turnover	4.13	2.67	1.85	1.71	1.86	1.95
Quick Ratio	1.36	1.28	1.37	2.18	2.09	3.44
Current Ratio	1.50	1.45	1.69	2.62	2.42	3.73
Return on Equity (ROE)	7.34%	1.65%	-11.38%	-5.00%	5.16%	11.01%
Return on Assets (ROA)	1.87%	1.99%	-4.86%	-2.61%	1.02%	6.29%
Return on Invested Capital (ROIC)	3.89%	2.09%	-11.36%	-6.79%	3.15%	16.79%
Return on Capital Employed (ROCE)	4.00%	4.30%	-10.20%	-4.80%	1.90%	9.30%
Earnings Yield	2.10%	0.73%	-4.72%	-2.12%	1.72%	1.71%
FCF Yield	-0.52%	0.29%	-6.90%	-11.39%	-4.95%	-1.02%
Dividend Yield	0.26%	0.37%	-	-	0.36%	0.20%
Payout Ratio	45.28%	138.60%	-	-	29.43%	7.81%
Buyback Yield / Dilution	-6.36%	0.74%	1.21%	-1.93%	-31.59%	-0.17%
Total Shareholder Return	-6.10%	1.10%	1.21%	-1.93%	-31.23%	0.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.